Építés alatt – nem éles oldal
Belépés

What researchers published on Pompe-betegség

1192 papers, newest first.

Showing 180 of 1192

  • Patient perspectives of participation in clinical studies in late-onset Pompe disease: Structured exit interviews from cipaglucosidase alfa plus miglustat studies.Therapeutic advances in rare disease
  • High-Risk Screening for Late-Onset Pompe Disease in Northern China: Prevalence, Genotypic Spectrum, and Diagnostic Challenges.JIMD reports
  • High-Fat, High-Protein, Carbohydrate-Restricted Dietary Interventions in Pompe Disease: A Case Series with Long-Term Follow-Up.Annals of nutrition & metabolism
  • A novel technology-driven enzyme replacement therapy for Pompe disease.Molecular therapy. Advances
  • ÁttekintésInfusion-associated reactions during enzyme replacement therapy in late-onset Pompe disease: a systematic review and proposed management algorithm.Molecular genetics and metabolism
  • EsetismertetésRecurrent Reactions to Enzyme Replacement Therapy in Infantile-Onset Pompe Disease: A Case of Immunologic Barriers to Drug Tolerance.American journal of medical genetics. Part A
  • EsetismertetésEarly Cardiac Involvement in Late-Onset Pompe Disease: A Case Report from an Iranian Consanguineous Family.Iranian journal of child neurology
  • Szisztematikus áttekintésThe Genetic Landscape of Pompe Disease in the Middle East, North Africa, and Turkey (MENAT Region): A Systematic Review of GAA Variants and Genotype-Phenotype Correlation.International journal of molecular sciences
  • Home-Based Versus Hospital-Based Administration of Enzyme Replacement Therapy for Late-Onset Pompe Disease in Greece: A Cost-Utility and Budget Impact Analysis.Applied health economics and health policy
  • Efficacy and safety of cipaglucosidase alfa plus miglustat in Japanese adults with late-onset Pompe disease: a case series from clinical trials.BMJ neurology open
  • ÁttekintésInfantile-Onset Pompe Disease: Current Therapeutic Landscape, Clinical Challenges, and Future Horizons.Cureus
  • Of Pompe and Circumstance: A Case Review of Late Onset Pompe Disease in a 52-Year-Old Male.Case reports in rheumatology
  • Evaluation of Pompe Disease from a Broad and Systemic Perspective.Journal of clinical practice and research
  • Identifying regulatory muscle processes in infantile and adult Pompe patients using a multi-omic and morphological approach.Brain pathology (Zurich, Switzerland)
  • Generation and characterization of a human iPSC line (XACHi022-A) derived from an asymptomatic carrier of the GAA c.2051C > A (p.P684Q) variant.Stem cell research
  • Two novel GAA missense variants and a known VUS in pompe disease: Functional characterization and pharmacological chaperone therapy.Genes & diseases
  • A High-Fat, High-Protein, Carbohydrate-Restricted Dietary Interventions in Pompe Disease: A Case Series with Long-Term Follow-Up.Annals of nutrition & metabolism
  • Nocturnal sleep abnormalities occur before motor function deterioration in early-treated patients with infantile-onset Pompe disease: a two-decade newborn screening cohort study.Neuromuscular disorders : NMD
  • Enzyme replacement therapy (ERT) combined with transient low-dose methotrexate (TLD-MTX) results in age- and disease-dependent immune profile changes in Infantile- vs. late-onset Pompe disease patients.Frontiers in immunology
  • EsetismertetésLate-Onset Pompe Disease.The New England journal of medicine
  • Megfigyeléses vizsgálatScreening for potential late-onset Pompe disease patients among individuals with suspected sleep apnea: A prospective, multicenter observational Cohort Study in Japan (PSSAP-J Study).Sleep & breathing = Schlaf & Atmung
  • Corrigendum to "Early detection in action: developing and refining newborn screening for Pompe disease in North Carolina" [Mol. Genet. Med. 149 (1-2) (2026) 110252].Molecular genetics and metabolism
  • Preliminary clinical application of two-dimensional speckle tracking echocardiography in adult-onset glycogen storage disease type II.Archives of physiology and biochemistry
  • The Effect of Anti-drug Antibodies on the Bioavailability of Alglucosidase Alfa in Classic Infantile Pompe Disease.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
  • ÁttekintésGenome Editing for Glycogen Storage Diseases.Journal of inherited metabolic disease
  • Epilepsy Is Part of the CNS Phenotype in Classic Infantile Pompe Disease.Neurology. Genetics
  • Early detection in action: developing and refining newborn screening for Pompe disease in North Carolina.Molecular genetics and metabolism
  • Functional characterization of 42 GAA missense variants using a validated in vitro cellular functional assay.Molecular genetics and metabolism
  • Nociceptive pain in late-onset Pompe disease: prevalence, distribution, and clinical correlates.Journal of neurology
  • GAA engineered to improve cellular uptake enhances correction in a preclinical hematopoietic stem cell gene therapy model of Pompe disease.Molecular therapy. Advances
  • A Protocol for Multidisciplinary Rehabilitation Combined with Enzyme Replacement Therapy for Ventilator Weaning in Late-Onset Pompe Disease.Journal of visualized experiments : JoVE
  • Pompe Disease: From a Cardiovascular Lens.Cardiology in review
  • Megfigyeléses vizsgálatExpiratory phase lung mechanics in late-onset Pompe disease: a multicenter study using oscillometry to identify specific breathing abnormalities.Orphanet journal of rare diseases
  • AAV9-mediated GAA gene therapy following enzyme replacement therapy discontinuation in children with infantile-onset Pompe disease.EClinicalMedicine
  • Disease duration and phenotypic heterogeneity in late-onset Pompe disease: Implications for individualized therapy.Molecular genetics and metabolism
  • ÁttekintésDefining the therapeutic corridor of stability in enzyme replacement therapy for Pompe disease: a position statement.Orphanet journal of rare diseases
  • Szisztematikus áttekintésCentral nervous system histopathological findings in classic infantile Pompe disease: a systematic review with clinical relevance.Journal of neurology
  • Home Infusion With Recombinant Human α-Glucosidase in Children With Pompe Disease: The Dutch Experience Over 20 Years Across the Spectrum From Classic Infantile to Late-Onset Phenotypes.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
  • Real-Life Effectiveness After Switching to Avalglucosidase Alfa in Late-Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study.European journal of neurology
  • A disease progression model comparing the long-term mobility and respiratory outcomes of adults with late-onset Pompe disease receiving cipaglucosidase alfa plus miglustat versus alglucosidase alfa.Journal of comparative effectiveness research
  • ÁttekintésA Comprehensive Update on Pompe Disease: From Existing Therapies to Emerging Curative Strategies.International journal of molecular sciences
  • Neonatal gene therapy with AAV2/8-LSPhGAA improves hypertrophic cardiomyopathy in the Gaac.1826dupA knock-in murine model.Molecular genetics and metabolism
  • Evaluation of electrical impedance myography as a noninvasive musculoskeletal biomarker in infantile- and late-onset Pompe disease.Genetics in medicine : official journal of the American College of Medical Genetics
  • Impact of Enzyme Replacement Therapy on Patients with Late Onset Pompe Disease - Real World Data from a Developing Country.Indian journal of pediatrics
  • Neonatal systemic gene therapy restores cardiorespiratory function in a rat model of Pompe disease.Molecular therapy : the journal of the American Society of Gene Therapy
  • Bayesian multivariate linear mixed-effects models with varied association structures.Statistical methods in medical research
  • Managing Pompe Disease and Enzyme Replacement Therapy During Pregnancy: Challenges and Considerations.European journal of neurology
  • Accumulation of membrane repair-associated proteins and mature myostatin are novel markers of muscle pathophysiology in Pompe disease.Acta neuropathologica communications
  • Pediatric sleep-disordered breathing in Pompe disease in the era of enzyme replacement therapy: A retrospective cohort study.Molecular genetics and metabolism
  • High prevalence of GAA c.[752C > T;761C > T] haplotype complicates high-risk screening for Pompe disease in the Chinese population.Molecular genetics and metabolism
  • EsetismertetésRhizobium radiobacter bloodstream infection associated with long-term central venous access in an infant with Pompe disease.Le infezioni in medicina
  • TRPML1 agonists synergize with enzyme replacement therapy in fibroblasts from Pompe disease patients.Journal of translational medicine
  • EsetismertetésWhen 'Liver Enzymes' Are Not Hepatic: Late-Onset Pompe Disease.The Medical journal of Australia
  • Longitudinal Assessment of Muscle Involvement in Late-Onset Pompe Disease Using Quantitative MRI: A Prospective Cohort Study.Journal of cachexia, sarcopenia and muscle
  • Quantitative Muscle MRI of the Lower Extremities Reveals Different Patterns of Involvement in Classic Infantile and Young Late-Onset Pompe Patients.Journal of inherited metabolic disease
  • Unfavorable cardiovascular risk profile without increased event prevalence in late-onset Pompe disease: an individually matched cohort study.Orphanet journal of rare diseases
  • EsetismertetésSensory neuronopathy secondary to gene therapy with AT845 for Pompe disease.Neuromuscular disorders : NMD
  • EsetismertetésCombined omalizumab and desensitization to control IgE-mediated hypersensitivity in enzyme replacement therapy for late-onset Pompe disease.Orphanet journal of rare diseases
  • [Clinical and genetic characteristics of infantile-onset Pompe disease​ and long-term efficacy of enzyme replacement therapy].Zhonghua er ke za zhi = Chinese journal of pediatrics
  • Clinical, pathological and genetic features as well as follow-up of 68 patients with late-onset Pompe disease: a single-center retrospective study.Frontiers in nutrition
  • The Value of Anti-Drug Antibody Detection in Discriminating Patients from Healthy Controls and Predicting the Gross Motor Functional State in Patients with Pompe Disease.Iranian journal of allergy, asthma, and immunology
  • Detection of Altered Muscle Glycogen- and NOE-Weighted CEST MRI Signals in an Acid Alpha-Glucosidase-Deficient Mouse Model of Pompe Disease Using QUASS-Enhanced Multi-Pool Quantitative CEST (QCEST) Imaging.Magnetic resonance in medicine
  • ÁttekintésPompe Disease: Pathogenesis, Molecular Mechanisms, Neurological Aspects, Diagnostics and Modern Therapeutic Approaches.International journal of molecular sciences
  • Szisztematikus áttekintésCardiac magnetic resonance in Pompe disease: a systematic literature review.La Radiologia medica
  • Cost-Effectiveness of Newborn Screening for Infantile-Onset Pompe Disease in Japan.International journal of neonatal screening
  • Dietary and body composition profiles in Chinese pediatric late-onset Pompe disease: implications for nutritional management.Frontiers in medicine
  • Antibody formation and efficacy of enzyme replacement therapy in adults with Pompe disease: Unlocking long-term insights.Genetics in medicine : official journal of the American College of Medical Genetics
  • Over ten years of newborn screening for LSDs in Tuscany (Italy): Epidemiology, novel variants, and the pseudodeficiency burden.Molecular genetics and metabolism
  • ÁttekintésEpigenetic modulation of the gut-muscle axis in pompe disease: Microbiota fingerprints to cellular and molecular pathomechanisms.Molecular metabolism
  • Restoration of lysosomal membrane integrity in cell models of Pompe disease depends on fatty acid synthase and its product palmitic acid.Cellular & molecular biology letters
  • Multidimensional assessment of diaphragmatic dysfunction in late-onset Pompe disease: a prospective cohort study.Orphanet journal of rare diseases
  • Early enzyme replacement therapy in late-onset Pompe disease diagnosed by newborn screening.Molecular genetics and metabolism
  • A genome-edited isogenic human embryonic stem cell model of pompe disease recapitulates cardiac and skeletal muscle pathology.Molecular biology reports
  • Increased Glycogenin-Exposed Residual Glycogen in Lysosomes Is the Early Pathological Finding in Asymptomatic Pompe Disease.Muscle & nerve
  • EsetismertetésManagement of life-threatening anaphylaxis to enzyme replacement therapy in an infant with Pompe disease: a case report and literature review.Frontiers in allergy
  • ÁttekintésGenetic Mutations Underlying Growth Impairment and Cardiomyopathies in Children: Molecular Mechanisms, Clinical Implications and Targeted Therapies.Genes
  • Patient Perspectives on Late-Onset Pompe Disease: Insights From a 2025 Patient Snapshot Survey on Diagnosis, Treatment, and Quality of Life.Journal of patient experience
  • EsetismertetésIntegration of deep intronic and RNA sequencing enhances molecular diagnosis in genetically unsolved Pompe cases.Molecular genetics and metabolism reports
  • Mapping lung function in late-onset Pompe disease using label-free functional MRI.iScience
  • Alglucosidase alfa demonstrates effectiveness and safety in Chinese patients with late-onset Pompe disease: A multi-center prospective study.Molecular genetics and metabolism
  • Identification of alterations of immunometabolism associated with Pompe disease.Cellular and molecular life sciences : CMLS
  • Impacts and Economic Burden of Pompe Disease on Patients and Families in Thailand: A Mixed Method Study.ClinicoEconomics and outcomes research : CEOR
  • Gait analysis reveals new outcome measures for monitoring disease progression in individuals with late-onset Pompe disease.Journal of neuroengineering and rehabilitation
  • EsetismertetésEarly-onset Pompe disease: an imaging spectrum.QJM : monthly journal of the Association of Physicians
  • ÁttekintésComprehensive review of recent advances in Pompe disease: pathogenesis, management, and future directions.Frontiers in neurology
  • Longitudinal Motor Function Changes in Adults With Late-Onset Pompe Disease: Key Determinants and Clinical Thresholds.Neurology
  • Design of multivalent pharmacological chaperones against Pompe disease via metal-free ligation.Organic & biomolecular chemistry
  • ÁttekintésMiglustat: a first-in-class enzyme stabilizer for cipaglucosidase alfa for the treatment of late-onset Pompe disease.Therapeutic advances in rare disease
  • MetaanalízisComparing the efficacy of cipaglucosidase alfa plus miglustat with alglucosidase alfa for late-onset Pompe disease: an expanded network meta-analysis utilizing patient-level and aggregate data.Journal of comparative effectiveness research
  • Generation and characterization of a novel Gaa compound heterozygous mouse model recapitulating human Pompe disease.Orphanet journal of rare diseases
  • Szisztematikus áttekintésLessons from late-onset Pompe disease identified by Newborn screening: A systematic review.Molecular genetics and metabolism
  • Mapping glycogen accumulation and treatment effect in Pompe disease with saturation transfer MRI.Translational research : the journal of laboratory and clinical medicine
  • EsetismertetésShort-Term Intensive Avalglucosidase Alfa Regimen in Late-Diagnosed Infantile Pompe Disease: A Case Report.Reports (MDPI)
  • Pompe disease: a country-wide molecular screening in a cohort of 15,068 study participants.Frontiers in molecular biosciences
  • Szisztematikus áttekintésEnzyme replacement therapy compared with best supportive care for the treatment of Pompe Disease: a systematic review and network meta-analysis.Health technology assessment (Winchester, England)
  • ÁttekintésA roadmap for a patient-centred approach to Pompe disease management.Journal of neurology
  • Megfigyeléses vizsgálatFirst multicenter real-world analysis of switching to next-generation enzyme replacement therapies in late-onset Pompe disease.Journal of neurology
  • Gastrointestinal manifestations and enzyme replacement therapy in late-onset Pompe disease: insights from a cross-sectional analysis.Orphanet journal of rare diseases
  • ÁttekintésMeasuring What Matters to Patients with Pompe Disease: A Review of Clinical Outcome Assessments for Capturing Treatment Benefits of Innovative Novel Therapies.Advances in therapy
  • Randomizált vizsgálatClinically important improvements in 6-minute walk distance and forced vital capacity in adults with late-onset Pompe disease switching from alglucosidase alfa to cipaglucosidase alfa plus miglustat in the PROPEL study.Neuromuscular disorders : NMD
  • Urinary glucose tetrasaccharide tracks disease activity in late-onset Pompe disease.Neuromuscular disorders : NMD
  • Safety of home administration of cipaglucosidase alfa plus miglustat in late-onset Pompe disease: results from multiple clinical trials.Therapeutic advances in rare disease
  • Longitudinal characterization of Gaac.1826dupA mice reveals the cardiac, myopathic and biochemical phenotypes of Pompe disease.Disease models & mechanisms
  • Early Initiation of Enzyme Replacement Therapy in Infantile Onset Pompe Disease Improves Cardiac Outcomes: A Longitudinal Analysis.JIMD reports
  • Szisztematikus áttekintésInsights into immunogenicity and therapeutic strategies to mitigate the immune response in infantile-onset Pompe disease: a comprehensive systematic literature review.Frontiers in immunology
  • ÁttekintésA comprehensive study on the effect of alglucosidase alpha and immunomodulation on survival, motor and cardiac outcome, creatine kinase and antibody titers in classic infantile Pompe disease: the Monza experience.Current opinion in immunology
  • GMPPB-CDG Results in Lysosomal Dysfunction and Acid Alpha-Glucosidase Deficiency.Journal of inherited metabolic disease
  • Quantitative MRI Biomarkers for Early Muscle Involvement in Late Onset Pompe Disease.Journal of inherited metabolic disease
  • EsetismertetésSuccessful desensitization to alglucosidase alfa in a very young infant with Pompe disease.Journal of pediatric endocrinology & metabolism : JPEM
  • Identification of miRNAs Associated with Infantile-Onset Pompe Disease.Molecular syndromology
  • Austrian Pompe Outcome Consensus (APOC): a national Delphi study.Orphanet journal of rare diseases
  • Early initiation of enzyme replacement therapy as facilitated by newborn screening improves health outcomes among patients with infantile-onset Pompe disease.Genetics in medicine open
  • EsetismertetésRapid Regression of Myocardial Hypertrophy with First-Line Avalglucosidase Alfa in Infantile-Onset Pompe Disease: A Case Report.Pediatric cardiology
  • Novel promoters drive therapeutic transgene expression and evade transgene-specific immune responses in a mouse model of Pompe disease.Molecular genetics and metabolism
  • Plasma glial fibrillary acidic protein (GFAP) is a biomarker for central nervous system involvement in infantile-onset Pompe disease.EBioMedicine
  • EsetismertetésIntegrating enzyme assay and molecular genetic testing for early diagnosis of infantile-onset Pompe disease: A case report.Molecular genetics and metabolism reports
  • Response to: Correspondence on 'Stability of alglucosidase alfa in 0.9% sodium chloride for enzyme replacement therapy in patients with Pompe disease: insights from enzyme activity and cellular uptake measurements' by Barzel et al.European journal of hospital pharmacy : science and practice
  • EsetismertetésEnzyme replacement therapy during pregnancy and breastfeeding in late-onset Pompe disease.International breastfeeding journal
  • Evaluation of Experienced Clinical Events in Pompe Disease Based on Real-life Data.Neuropediatrics
  • ÁttekintésDiagnosis, management and monitoring of patients with Pompe disease in the UK.BMJ neurology open
  • IrányelvRecommendations for the diagnosis, treatment, and follow-up of late-onset Pompe disease.Neurologia
  • ÁttekintésNew advances in treating late-onset Pompe Disease: A narrative review.European journal of pediatrics
  • Correspondence on "Stability of alglucosidase alfa in 0.9% sodium chloride for enzyme replacement therapy in patients with Pompe disease: insights from enzyme activity and cellular uptake measurements" by Barzel et al.European journal of hospital pharmacy : science and practice
  • Neutral sp2-iminosugars exploiting non-glycone interactions for selective acid α- and β-glucosidase activity modulation: Pharmacological chaperones for Gaucher and Pompe diseases.European journal of medicinal chemistry
  • Correction: Can Alpha-Glucosidase Activity in Plasma or Leukocytes Serve as a Biomarker for Future Gene Therapy in Classic Infantile Pompe Disease?BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
  • Focused ultrasound delivery of enzyme replacement therapy to the brain of Gaa-/- Pompe disease mice.Molecular genetics and metabolism
  • A respiratory signature of disease progression in the Pompe rat.Journal of neurophysiology
  • ÁttekintésEnzyme Replacement Therapy & Other Therapeutic Frontiers in Infantile Metabolic Disorders.NeoReviews
  • Late-onset Pompe's disease in pediatrics: results from an Italian national survey on 38 patients and proposal of a targeted diagnostic algorithm.Orphanet journal of rare diseases
  • Elevated Transaminases: Does It Always Warrant a Liver Biopsy? Lessons Learned From Pompe Disease.JIMD reports
  • Can Alpha-Glucosidase Activity in Plasma or Leukocytes Serve as a Biomarker for Future Gene Therapy in Classic Infantile Pompe Disease?BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
  • Megfigyeléses vizsgálatLong-term safety outcomes and patient preferences for home-based intravenous enzyme replacement therapy (ERT) in Pompe disease and Mucopolysaccharidosis Type I (MPS-I): final results of two-year observation.Orphanet journal of rare diseases
  • EsetismertetésCipaglucosidase alfa plus miglustat in Pompe disease: two non-ambulatory patients switching from high‑dose, high-frequency alglucosidase alfa.Neuromuscular disorders : NMD
  • The cost-effectiveness of enzyme replacement therapies versus best supportive care for treating late onset Pompe disease in the UK NHS.The European journal of health economics : HEPAC : health economics in prevention and care
  • EsetismertetésPresymptomatic late-onset Pompe disease: Optimizing the timing of treatment.Revue neurologique
  • When the Diaphragm Fails: Visual Hallucinations Due to Isolated Respiratory Muscle Weakness as a First Manifestation of Late-Onset Pompe Disease.European journal of case reports in internal medicine
  • Hypertrophic cardiomyopathy in Pompe disease following avalglucosidase alfa therapy.Anales de pediatria
  • ÁttekintésRe-anchoring the Value of Innovative Therapies in NICE Decision Making When Comparators are Cost Ineffective: A Case Study of Late-Onset Pompe Disease.PharmacoEconomics
  • Megfigyeléses vizsgálatMedical expenses and care pathways of patients with Pompe receiving myozyme: an observational study based on the French national healthcare database.Orphanet journal of rare diseases
  • EsetismertetésAnaesthetic Management of Advanced Late-Onset Pompe Disease: Challenges in a Major Abdominal Surgery.Cureus
  • A retrospective cohort study describing the disease burden in patients with Pompe disease treated with enzyme replacement therapy in the United States.Journal of neuromuscular diseases
  • Causes of Death and Comorbidities in Adult Patients With Late-Onset Pompe Disease: A French Pompe Registry Retrospective Study.European journal of neurology
  • Editorial Note: The Pharmacological Chaperone AT2220 Increases Recombinant Human Acid α-Glucosidase Uptake and Glycogen Reduction in a Mouse Model of Pompe Disease.PloS one
  • EsetismertetésDermatomyositis masking late onset Pompe disease in a patient with proximal muscle weakness.Journal of neuromuscular diseases
  • EsetismertetésIn Thickness and in Health: Delayed-Onset Pompe Disease Resembling Hypertrophic Cardiomyopathy.Cureus
  • Megfigyeléses vizsgálatQuantification of muscle glycogen distribution in Pompe disease using 7 Tesla 13C NMR spectroscopy.Journal of neurology, neurosurgery, and psychiatry
  • Reduction of false-positive results with biochemical second-tier testing for newborn screening of Pompe disease.Genetics in medicine : official journal of the American College of Medical Genetics
  • Molecular characterization of a novel synonymous variant in a Mexican patient with Pompe disease.Molecular genetics and metabolism reports
  • Áttekintés[Neuromuscular diseases in pediatrics with specific treatments].Medicina
  • Quantitative muscle ultrasound as a window into disease progression in infantile-onset Pompe disease.Molecular genetics and metabolism
  • Infantile-onset Pompe disease entering adulthood: Insights from 2 decades of enzyme replacement therapy experience.Genetics in medicine : official journal of the American College of Medical Genetics
  • Umbilical Cord Blood Sampling for Newborn Screening of Pompe Disease and the Detection of a Novel Pathogenic Variant and Pseudodeficiency Variants in an Asian Population.International journal of neonatal screening
  • Correction of Disease Phenotype in Pompe Disease Knockout Mice Following Cationic Lipid-GL-67-Mediated Gene Therapy.DNA and cell biology reports
  • C-Branched Iminosugars as Selective Pharmacological Chaperones of Lysosomal α-Glucosidase for the Treatment of Pompe Disease.Journal of medicinal chemistry
  • Genotype-phenotype correlation and CRIM status in Vietnamese children with Pompe disease: a single-center experience.Future science OA
  • ÁttekintésPompe Disease: A Review of Diagnosis, Molecular Genetics, and Treatment Management.Current cardiology reviews
  • Management of hypersensitivity in a patient with late-onset Pompe disease experiencing recurrent infusion-related reactions.Journal of neurology
  • Therapeutic acute intermittent hypoxia modestly improves breathing in Pompe disease.Respiratory physiology & neurobiology
  • A myotropic AAV vector combined with skeletal muscle cis-regulatory elements improve glycogen clearance in mouse models of Pompe disease.Molecular therapy. Methods & clinical development
  • An Indirect Treatment Comparison of Avalglucosidase Alfa versus Cipaglucosidase Alfa Plus Miglustat in Patients with Late-Onset Pompe Disease.Advances in therapy
  • EsetismertetésMarked Improvements in Airway Abnormalities and Multifaceted Outcomes After 2 Years Switching to Avalglucosidase Alfa: Evaluation of A 19-Year-Old Male Diagnosed With Late-Onset Pompe Disease.American journal of medical genetics. Part A
  • ÁttekintésNavigating the Emotional and Practical Challenges of Newborn Screening for Late-Onset Pompe Disease: Insights From Parental Perspectives.Pediatric neurology
  • Efficacy of avalglucosidase alfa in infantile-onset Pompe disease with high anti-alglucosidase alfa antibody titers.Pediatrics international : official journal of the Japan Pediatric Society
  • A retrospective cohort study of the economic burden of Pompe disease in patients treated with enzyme replacement therapy in the United States.Journal of medical economics
  • Generation and characterization of three human induced pluripotent stem cell lines from patients with glycogen storage disease type II.Stem cell research
  • Cipaglucosidase alfa and miglustat for treatment of late-onset Pompe disease (LOPD): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG).Genetics in medicine open
  • Novel transferrin receptor-mediated enzyme replacement therapy efficiently treats myogenic and neurogenic aspects of Pompe disease in mice.Molecular therapy. Methods & clinical development
  • Molecular Screening of Feline Glycogen Storage Disease Type II (Pompe Disease): Allele Frequencies of the GAA:c.1799G>A and c.55G>A Variants.Genes
  • Identification of a Pathogenic Mutation for Glycogen Storage Disease Type II (Pompe Disease) in Japanese Quails (Coturnix japonica).Genes
  • MetaanalízisEnzyme replacement therapy for the treatment of late onset Pompe disease: A systematic review and network meta-analysis.Orphanet journal of rare diseases
  • Determination of the Epitopes of Alpha-Glucosidase Anti-Drug Antibodies in Pompe Disease Patient Plasma Samples.Antibodies (Basel, Switzerland)
  • EsetismertetésAn uncommon case of neonatal asphyxia associated with infantile-onset Pompe disease.Italian journal of pediatrics
  • Stability of alglucosidase alfa in 0.9% sodium chloride for enzyme replacement therapy in patients with Pompe disease: insights from enzyme activity and cellular uptake measurements.European journal of hospital pharmacy : science and practice
  • Randomizált vizsgálatEfficacy and safety of avalglucosidase alfa in patients with late-onset Pompe disease after 145 weeks of treatment during the COMET trial.Journal of neurology
  • Extensive digital health technology assessment detects subtle motor impairment in mild and asymptomatic Pompe disease.Scientific reports
  • Efficacy of Switching Therapy From Alglucosidase Alfa to Avalglucosidase Alfa on Respiratory Function in Participants With Late-Onset Pompe Disease: A Post Hoc Analysis From the COMET Trial.JIMD reports
  • ÁttekintésLatest Advancements in Treatment Options for Infantile-Onset Pompe Disease: A Comprehensive Narrative Review.Clinical medicine insights. Pediatrics
  • EsetismertetésAtrioventricular Block in a Pompe Disease Patient Receiving Enzyme Replacement Therapy.JACC. Case reports
  • Correction: Changes in forced vital capacity over ≤ 13 years among patients with late-onset Pompe disease treated with alglucosidase alfa: new modeling of real-world data from the Pompe Registry.Journal of neurology
  • Autophagy impairment is associated with enhanced satellite cell activation in muscle biopsies from younger late-onset Pompe disease patients.Journal of neuropathology and experimental neurology